Readystate Asset Management LP Cytokinetics Inc Transaction History
Readystate Asset Management LP
- $3.27 Trillion
- Q2 2025
A detailed history of Readystate Asset Management LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Readystate Asset Management LP holds 132,218 shares of CYTK stock, worth $7.96 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
132,218
Previous 148,169
10.77%
Holding current value
$7.96 Million
Previous $5.95 Billion
26.64%
% of portfolio
0.13%
Previous 0.2%
Shares
7 transactions
Others Institutions Holding CYTK
# of Institutions
371Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.06 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$883 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$721 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$471 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$383 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.66B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...